LBPH
Price:
$34.86
Market Cap:
$1.36B
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.[Read more]
Industry
Biotechnology
IPO Date
2021-03-12
Stock Exchange
NASDAQ
Ticker
LBPH
According to Longboard Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.35B. This represents a change of 153.57% compared to the average of 530.54M of the last 4 quarters.
The mean historical Enterprise Value of Longboard Pharmaceuticals, Inc. over the last ten years is 106.35M. The current 1.35B Enterprise Value has changed 126.40% with respect to the historical average. Over the past ten years (40 quarters), LBPH's Enterprise Value was at its highest in in the June 2024 quarter at 1.19B. The Enterprise Value was at its lowest in in the March 2021 quarter at -9296533.34.
Average
106.35M
Median
84.53M
Minimum
17.48M
Maximum
238.84M
Discovering the peaks and valleys of Longboard Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 168.51%
Maximum Annual Enterprise Value = 238.84M
Minimum Annual Increase = -92.68%
Minimum Annual Enterprise Value = 17.48M
Year | Enterprise Value | Change |
---|---|---|
2023 | 123.18M | 168.51% |
2022 | 45.88M | 162.45% |
2021 | 17.48M | -92.68% |
The current Enterprise Value of Longboard Pharmaceuticals, Inc. (LBPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
62.18M
5-year avg
106.35M
10-year avg
106.35M
Longboard Pharmaceuticals, Inc.’s Enterprise Value is greater than Molecular Partners AG (-1929773.37), greater than MediciNova, Inc. (59.15M), greater than Anebulo Pharmaceuticals, Inc. (41.53M), greater than Champions Oncology, Inc. (62.59M), greater than Cyteir Therapeutics, Inc. (-20511738.00), greater than Werewolf Therapeutics, Inc. (-10348556.00), less than Edgewise Therapeutics, Inc. (1.60B), greater than Decibel Therapeutics, Inc. (96.42M), greater than Celcuity Inc. (623.73M), greater than C4 Therapeutics, Inc. (369.73M), greater than Assembly Biosciences, Inc. (90.35M), greater than NextCure, Inc. (25.04M), greater than Nuvation Bio Inc. (947.94M), greater than Graphite Bio, Inc. (-15007658.00), greater than Instil Bio, Inc. (171.51M), greater than Sensei Biotherapeutics, Inc. (8.47M), greater than Merrimack Pharmaceuticals, Inc. (-10189682.00), greater than Monte Rosa Therapeutics, Inc. (284.72M), greater than Design Therapeutics, Inc. (221.42M), greater than Ikena Oncology, Inc. (46.38M), greater than Stoke Therapeutics, Inc. (586.20M),
Company | Enterprise Value | Market cap |
---|---|---|
-1929773.37 | $182.90M | |
59.15M | $103.00M | |
41.53M | $46.68M | |
62.59M | $57.77M | |
-20511738.00 | $108.71M | |
-10348556.00 | $88.28M | |
1.60B | $1.64B | |
96.42M | $123.37M | |
623.73M | $557.67M | |
369.73M | $374.42M | |
90.35M | $107.81M | |
25.04M | $39.73M | |
947.94M | $692.60M | |
-15007658.00 | $185.19M | |
171.51M | $92.68M | |
8.47M | $15.32M | |
-10189682.00 | $223.97M | |
284.72M | $349.21M | |
221.42M | $264.42M | |
46.38M | $81.56M | |
586.20M | $773.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Longboard Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Longboard Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Longboard Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Longboard Pharmaceuticals, Inc. (LBPH)?
What is the 3-year average Enterprise Value for Longboard Pharmaceuticals, Inc. (LBPH)?
What is the 5-year average Enterprise Value for Longboard Pharmaceuticals, Inc. (LBPH)?
How does the current Enterprise Value for Longboard Pharmaceuticals, Inc. (LBPH) compare to its historical average?